Home | About | RSS Feed | Contact and Publicity Guidelines | Comment Policy the Law, the Universe, and Everything 

advertise-here4


Slip Opinions


Health care ourobouros. (fp)

Liberty vindicated. (fp)

The converging austerity & penality agendas. (fp)

WSJ on Kevin Costner's bison contract dispute, noting my forthcoming book on "celebrity contract disputes."  LAC

Groundhog Day. (fp)

Banned in Tucson. (kw)

The Best and Worst of 2011 in Race and Law (kw)

Tortured to death for trespassing. (fp)

Drones of contention. (fp)

DOJ still coddling banks. (fp)


solicitors

Our Podcast

Subscribe to Law Talk

law-rev-contents2.jpg


  • Posts by Author

  • Categories

  • Archives


  • Recent Comments


    • Bob Lawless on The Law Professor's Role

    • Jarod Bona on The AIG Story with Hank Greenberg

    • Chris Robinette on James Wilson

    • A.J. Sutter on Podcasts About TV About Law

    • Spencer Waller on James Wilson

    • Joe on James Wilson

    • Carlton Larson on James Wilson

    • Gerard Magliocca on The AIG Story with Hank Greenberg

    • Gerard Magliocca on James Wilson

    • dave hoffman on James Wilson

    • Justin on What is Federalism?

    • wb on James Wilson

    • Kirsten on What is Federalism?

    • Joe on James Wilson

    • Howard Wasserman on Jeffrey Toobin on Citizens United
  •  

    Site Meter

    About the Blog

    Concurring Opinions is a multiple authored, general interest legal blog.

    (Image: Wikicommons)

Author Archive for russell-korobkin

Stem Cell Research and the Presidential Race

posted by Russell Korobkin

Thanks to Dan and Frank for inviting to blog about my new book, Stem Cell Century: Law and Politics for a Breakthrough Technology. The book analyzes a broad range of issues related to stem cell research and regenerative medicine. Only one chapter out of 10 (“The Embryo Wars”) considers the debate over the ethics of conducting research that requires the destruction of human embryos and the Bush policy of severely limiting federal funding of research on stem cell lines derived from embryos. But the announcement, two weeks ago, that two teams of scientists have succeeded in reprogramming adult cells to behave like embryonic stem cells has the potential to open a new chapter of the embryo wars that will play out in the presidential campaign.

Two weeks ago, it seemed pretty clear that embryonic stem cell research was a wedge issue that the Democrats would exploit in the 2008 election. All of the Democratic candidates not only favor federal funding of research on stem cell lines derived from embryos, they are quick to point out their position and criticize Presiden’t Bush’s funding restrictions. Most Americans, including most Democrats, most independents, and perhaps half of Republicans, support the research. The Republican candidates, on the other hand, tend to downplay the issue, whether they appear to support the research (McCain, Giuliani) or oppose it (Thompson, Romney–although the latter has changed his position, as he has on many issues, since he was the governor of Massachusetts), because the issue tends to split religious conservatives and economic conservatives.

The cell reprogramming success has not weakened the commitment to embryonic stem cell research of most members of the scientific community, because it is too early to tell whether the new cells – called induced pluripotent stem cells – will actually be as useful as embryonic stem cells, and because the new cells are made by inserting genes (which can cause cancer) with retroviruses (which can cause cancer). Not only does this mean that the IPS cells could not be used to create treatments that would be injected into humans (a long-term goal of stem cell research), it also suggests that they might not serve as good models of diseases for the more immediate goals of stem cell research: studying how degenerative conditions develop and creating large quantities of diseased cells in order to more efficiently screen chemical compounds that might be effective as treatments. Some prominent scientists believe the drawbacks of IPS cells at the current time are likely to be overcome; others think they are not.

The average American swing voter might not see things quite this way, however. Many people who favor embryonic stem cell research find the destruction of early-stage embryos troubling but justified by the potential medical benefits. Voters in this group might think that the creation of IPS cells has changed the cost-benefit analysis. A number of conservative commentators have already argued aggressively that the IPS discovery vindicates the Bush funding policy and shows that neither medical research nor ethics need to be compromised, and the Romney campaign issued a press release saying essentially the same thing. Meanwhile, all the pro-research candidates – Democrats and Republicans – have been noticeably silent the issue since the IPS announcement. I haven’t seen a statement or comment by any of them (if any readers have, please let me know). My guess is they are waiting to see polls that show whether the majority of Americans still favor embryo research. For the first time since 2001, the pro-research side is now on the defensive.

  December 3, 2007 at 10:19 am   Posted in: Bioethics, Health Law, Politics  Print This Post Print This Post   One Comment




Authors

Daniel J. Solove
Kaimipono Wenger
Dave Hoffman
Frank Pasquale
Deven Desai
Danielle Citron
Lawrence Cunningham
Sarah Waldeck
Jaya Ramji-Nogales
Solangel Maldonado
Gerard Magliocca

Guests

Khiara Bridges
andré douglas pond cummings
Susan Freiwald
Angela Harris
Janai Nelson
Robert Percival
Brishen Rogers
Peter Swire
Elizabeth A. Wilson















Previous Guests

Michael Abramowicz
Michelle Adams
Robert Ahdieh
Marvin Ammori
Michelle Anderson
Laura Appleman
Derek Bambauer
Taunya Lovell Banks
Ann Bartow
Steven Bellovin
Adam Benforado
Gaia Bernstein
Francesca Bignami
Josh Blackman
Joseph Blocher
Jeremy Blumenthal
Kathleen Boozang
Bruce Boyden
Donald Braman
Al Brophy
Neil H. Buchanan
Bill Burke-White
Scott Burris
Paul Butler
Ryan Calo
Naomi Cahn
Anupam Chander
Miriam Cherry
Jack Chin
Glenn Cohen
Gabriella Coleman
Jennifer Collins
Caroline Mala Corbin
Thomas Crocker
Allison Danner
Brannon Denning
Deven Desai
Mike Dimino
Mark Edwards
Maxine Eichner
Jessica Erickson
David Fagundes
Lisa Fairfax
Joshua Fairfield
Christine Haight Farley
Kim Ferzan
Dan Filler
Mary Anne Franks
Michael Froomkin
Amanda Frost
Brian Frye
Timothy Glynn
Rachel Godsil
Eric Goldman
Kyle Graham
David Gray
Craig Green
Tristin Green
Jonathan Hafetz
Meredith Harbach
Michelle Harner
Jeffrey Harrison
Hosea Harvey
Erica Hashimoto
Jennifer Hendricks
Carissa Hessick
Laura Heymann
Robert Hillman
Gilbert A. Holmes
Nicole Huberfeld
Christine Hurt
Darian Ibrahim
Sherrilyn Ifill
John Ip
Shavar Jeffries
Kevin Johnson
Kristin Johnson
Jeff Jonas
Courtney Joslin
Dan Kahan
Jeffrey Kahn
Brian Kalt
Sam Kamin
Michael Kang
Chimène Keitner
Alicia Kelly
Orin Kerr
Nancy Kim
Heidi Kitrosser
Adam Kolber
Russell Korobkin
Alex Kreit
Anita S. Krishnakumar
Susan Kuo
Greg Lastowka
Sarah Lawsky
Youngjae Lee
Margaret Lewis
Erik Lillquist
Jeff Lipshaw
Jonathan Lipson
Jacqueline Lipton
Matthew Lister
Joseph Liu
Michael Madison
Kevin Noble Maillard
Solangel Maldonado
Jason Mazzone
Linda McClain
William McGeveran
Salil Mehra
Carrie Menkel-Meadow
Max Minzner
Viva Moffat
Scott Moss
Eric Muller
Jaya Ramji-Nogales
Helen Norton
Elizabeth Nowicki
Paul Ohm
Angela Onwuachi-Willing
Michael O'Shea
David Opderback
Kristen Osenga
Rafael Pardo
Marcy Peek
Eduardo Peñalver
Robert Percival
Michael J. Pitts
Marc Poirier
David Post
Amanda Pustilnik
Shruti Rana
Geoffrey Rapp
Neil Richards
Lori Ringhand
Alice Ristroph
Marc Roark
Sasha Romanosky
Tuan Samahon
Susan Scafidi
David Schraub
Paul Secunda
Jonathan Siegel
Jessica Silbey
Peter Smith
Judd Sneirson
Adam Steinman
Charles Sullivan
Rick Swedloff
Olivier Sylvain
Steph Tai
Andrew Taslitz
Robert Tsai
Jenia Turner
Joseph Turow
Steve Vladeck
Ari Waldman
Spencer Weber Waller
Howard Wasserman
Melissa Waters
Frank Wu
Alfred Yen
Corey Yung
David Zaring
Timothy Zick
Michael Zimmer
Jonathan Zittrain

Ownership

Concurring Opinions is a
general-interest legal blog
operated by Concurring
Opinions LLC, a Pennsylvania
Limited Liability Corporation.

Blogroll

Above the Law
Access to Justice
ACS Blog
Althouse
Balkinization
Becker-Posner Blog
BlackProf
BoingBoing
Chicago Law Faculty Blog
Conglomerate
CrimLaw
Crime & Federalism
CrimProf Blog
Crooked Timber
Derechoalderecho
Discourse.net
Dorf on Law
Election Law
Emergent Chaos
The Faculty Lounge
Feminist Law Profs
43(B)log
Freakonomics Blog
Freedom to Tinker
Google Blogoscoped
How Appealing
Ideoblog
Info/Law
Instapundit.com
Juris Novus
Jurisdynamics
Just Books
Law and Humanities Blog
Law and Letters
Law Librarian Blog
Legal Profession Blog
Legal Theory Blog
Legal Times Blog
Leiter Reports
Brian Leiter's Law School Reports
Lessig Blog
Madisonian Theory
Media Law Blog
Mirror of Justice
The Moderate Voice
National Security Advisors
Opinio Juris
Point of Law
PrawfsBlawg
ProfessorBainbridge.com
Property Prof Blog
Red Tape Chronicles
The Right Coast
Schneier on Security
SCOTUSBlog
Security Dilemmas
Sentencing Law and Policy
Simple Justice
Sivacracy.net
The Situationist
Susan Crawford
TalkLeft
Talking Points Memo
TaxProf Blog
TeachPrivacy Blog
Tech & Marketing Law
Truth on the Market
Volokh Conspiracy
WorkPlace Prof Blog
WSJ Law Blog
Wonkette
The Yin Blog


© Concurring Opinions

Powered by WordPress